Cas:149354-10-9 tert-butyl 7-hydroxy-1,2,4,5-tetrahydro-3-benzazepine-3-carboxylate manufacturer & supplier

We serve Chemical Name:tert-butyl 7-hydroxy-1,2,4,5-tetrahydro-3-benzazepine-3-carboxylate CAS:149354-10-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

tert-butyl 7-hydroxy-1,2,4,5-tetrahydro-3-benzazepine-3-carboxylate

Chemical Name:tert-butyl 7-hydroxy-1,2,4,5-tetrahydro-3-benzazepine-3-carboxylate
CAS.NO:149354-10-9
Synonyms:tert-butyl 7-hydroxy-1,2,4,5-tetrahydro-3H-3-benzazepine-3-carboxylate;3-tert-butyloxycarbonyl-7-hydroxy-1H-2,3,4,5-tetrahydro-3-benzazepine
Molecular Formula:C15H21NO3
Molecular Weight:263.33200
HS Code:2933990090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:49.77000
Exact Mass:263.15200
LogP:2.66580

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like tert-butyl 7-hydroxy-1,2,4,5-tetrahydro-3H-3-benzazepine-3-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-tert-butyloxycarbonyl-7-hydroxy-1H-2,3,4,5-tetrahydro-3-benzazepine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,tert-butyl 7-hydroxy-1,2,4,5-tetrahydro-3H-3-benzazepine-3-carboxylate Use and application,3-tert-butyloxycarbonyl-7-hydroxy-1H-2,3,4,5-tetrahydro-3-benzazepine technical grade,usp/ep/jp grade.


Related News: The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses. tert-butyl 7-hydroxy-1,2,4,5-tetrahydro-3-benzazepine-3-carboxylate manufacturer Trial results demonstrated that Oligomannate statistically improved cognitive function in mild-to-moderate AD patients as early as week 4 and the benefit was sustained at each follow-up assessment visit,�� Shanghai Green Valley Pharmaceuticals, which developed the drug along with two academic institutions in China, said in a statement. tert-butyl 7-hydroxy-1,2,4,5-tetrahydro-3-benzazepine-3-carboxylate supplier Beta Bionics is pursuing regulatory approval of its insulin-only bionic pancreas, followed by its dual-hormone system, which will also administer a glucagon analog in order to raise blood-sugar levels without the need to consume carbohydrates. Beta Bionics operates in Massachusetts and California. tert-butyl 7-hydroxy-1,2,4,5-tetrahydro-3-benzazepine-3-carboxylate vendor The Department of Health and Human Services asked the Defense Department to provide several facilities capable of housing at least 250 people in individual rooms through to February 29, the Pentagon said. tert-butyl 7-hydroxy-1,2,4,5-tetrahydro-3-benzazepine-3-carboxylate factory The Department of Health and Human Services asked the Defense Department to provide several facilities capable of housing at least 250 people in individual rooms through to February 29, the Pentagon said.